Menin-MLL inhibitor-22 CAS No.2851841-61-5
Menin-MLL inhibitor-22 CAS No.2851841-61-5
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2607 | 5mg | 330.00 | + Add to cart |
|
| R-R-2607 | 10mg | 550.00 | + Add to cart |
|
|
|
||||
Product description
Menin-MLL inhibitor-22 (compound C20)/CAS No.2851841-61-5 is an orally active inhibitor of the interaction between menin and mixed lineage leukemia (MLL) (IC50=7 nM). Menin-MLL inhibitor-22 binds menin protein and inhibits cancer cell growth (MV4 cells, IC50=0.3 μM). Menin is a putative tumor suppressor associated with multiple endocrine neoplasia type 1 (MEN-1 syndrome).
| Appearance | N/A |
|---|---|
| Molecular Weight | 565.73 |
| Purity | >90% |
| CAS | 2851841-61-5 |
| Formula | C29H39N7O3S |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Menin-MLL inhibitor-22 CAS No.2851841-61-5
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


